1109 - A multicenter, observational study to compare the effectiveness of eftazidim vibactam versus eftolozane azobactam for multidrug-resistant Pseudomonas aeruginosa infections in the United States (CACTUS)

Friday, October 13, 2023

10:30 AM – 10:42 AM US ET

Location: 102 AB

Presenting Author(s)

Ryan K. Shields, PharmD, MS

Associate Professor of Medicine
University of Pittsburgh
Pittsburgh, PA, United States

Slides

Co-Author(s)

Lilian M. Abbo, MD, MBA (she/her/hers)

Professor of Infectious Diseases; Associate Chief Medical Officer in Infectious Diseases
University of Miami Miller School of Medicine, Miami Transplant Institute and Jackson Health System
Miami, FL, United States
RA

Renee Ackley, PharmD, BCPS, BCIDP

Infectious Diseases Pharmacist
Atrium Health
Charlotte, North Carolina, United States
Samuel L. Aitken, PharmD, MPH

Clinical Pharmacist Specialist
Michigan Medicine
Ann Arbor, MI, United States
BA

Benjamin Albrecht, PharmD

Emory University
Atlanta, Georgia, United States
Ahmed Babiker, MBBS, MSc (he/him/his)

Assistant Professor
Emory University School of Medicine
Atlanta, GA, United States
RC

Renzo Cifuentes, MD

University of Miami Miller School of Medicine
Miami, Florida, United States
Kimberly C. Claeys, PharmD (she/her/hers)

Associate Professor
University of Maryland Baltimore
Baltimore, MD, United States
KD

Kathryn DeSear, PharmD, BCIDP

Clinical Infectious Diseases Pharmacist
University of Florida Health Shands Hospital
Gainesville, Florida, United States
Jason C. Gallagher, PharmD

Clinical Professor
Temple University School of Pharmacy
Philadelphia, PA, United States
EG

Eric Gregory, PharmD

Infectious Diseases/Antimicrobial Stewardship Pharmacist
The University of Kansas Health System
Kansas City, MO, United States
Emily L. Heil, PharmD, MS

Professor
University of Maryland School of Pharmacy
Baltimore, MD, United States
CH

Carissa Hickey, PharmD Candidate

Temple University School of Pharmacy
Lititz, Pennsylvania, United States
Megan Klatt, PharmD, BCIDP (she/her/hers)

Infectious Diseases/Antimicrobial Stewardship Pharmacist
The University of Kansas Health System, KS, United States
EK

Ellen G. Kline, MS

University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Ryan C. Kubat, DO

Assistant Professor
University of Kansas
Kansas City, Kansas, United States
Wesley D. Kufel, PharmD, BCPS, BCIDP, AAHIVP

Clinical Associate Professor
Binghamton University School of Pharmacy and Pharmaceutical Sciences
Binghamton, NY, United States
JL

Jae Hyoung Lee, MD

Johns Hopkins
Baltimore, Maryland, United States
AL

Ahmi Lim, PharmD

University of California, San Francisco (UCSF) Medical Center
San Francisco, California, United States
TL

Theresa Lingg, RN

University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Conan MacDougall, PharmD, MAS (he/him/his)

Professor of Clinical Pharmacy
University of California San Francisco
San Francisco, CA, United States
Amy Mathers, MD, D(ABMM) (she/her/hers)

Associate Professor of Medicine and Pathology
University of Virginia
Charlottesville, VA, United States
Erin K. McCreary, PharmD (she/her/hers)

Director of Infectious Diseases Improvement and Clinical Research Innovation
University of Pittsburgh Medical Center
Pittsburgh, PA, United States
William Justin Moore, PharmD, BCPS, BCIDP (he/him/his)

Practice Coordinator, Antimicrobial & Diagnostic Stewardship
Northwestern Medicine
Chicago, Illinois, United States
SO

Shannon Olson, BS Pharm,BCIDP

Infectious Diseases Pharmacist
Sinai-Grace Hospital Detroit Medical Center
Detroit, Michigan, United States
JO

Jessica Oxer, n/a

Weill Cornell Medicine
New York, New York, United States
Jeffrey C. Pearson, PharmD

Clinical Pharmacy Specialist, Infectious Diseases
Brigham and Women's Hospital
Boston, Massachusetts, United States
Christine Pham, PharmD, BCIDP

Infectious Diseases Clinical Pharmacist
University of California, Los Angeles; David School of Medicine/University of California, Los Angeles
Los Angeles, California, United States
CP

Christopher Polk, MD

Associate Professor
Atrium Health
Charlotte, North Carolina, United States
Michael J. Satlin, MD

Associate Professor
Weill Cornell Medicine
New York, NY, United States
SS

Sarah W. Satola, PhD

Associate Professor
Emory University School of Medicine, Division of Infectious Diseases
Atlanta, Georgia, United States
Sunish Shah, PharmD

ID pharmacist
Antibiotic Management Program, UPMC Presbyterian Hospital, Pittsburgh, PA
Pittsburgh, Pennsylvania, United States
YS

Yash B. Solanki, PharmD Candidate

Temple University School of Pharmacy
Lansdale, Pennsylvania, United States
Pranita Tamma, MD, MHS

Associate Professor
Johns Hopkins School of Medicine
Baltimore, MD, United States
AV

Ana Vega, PharmD

Clinical Hospital Pharmacist- Infectious Diseases
Jackson Memorial Hospital
Miami, Florida, United States
Venugopalan Veena, PharmD

Associate Professor
University of Florida, College of Pharmacy
Gainesville, Florida, United States
MV

Michael Veve, PharmD, MPH

Infectious Diseases Pharmacist
Henry Ford Health
Detroit, Michigan, United States
Walaiporn Wangchinda, MD

Research fellow
University of Michigan College of Pharmacy
Ann Arbor, Michigan, United States
Lucy S. Witt, MD, MPH, MSc (she/her/hers)

Assistant Professor
Emory University
Atlanta, GA, United States
JW

Janet Wu, PharmD

Infectious Diseases Clinical Pharmacist
Cleveland Clinic
Cleveland, Ohio, United States
jason M. Pogue, PharmD

Clinical Professor
University of Michigan, College of Pharmacy
Ann Arbor, Michigan, United States

Disclosure(s):

Ryan K. Shields, PharmD, MS: Allergan: Advisor/Consultant (); Cidara: Advisor/Consultant (); Entasis: Advisor/Consultant (); GSK: Advisor/Consultant (); Melinta: Advisor/Consultant (), Grant/Research Support (); Menarini: Advisor/Consultant (); Merck: Advisor/Consultant (), Grant/Research Support (); Pfizer: Advisor/Consultant (); Roche: Grant/Research Support (); Shionogi: Advisor/Consultant (), Grant/Research Support (); Utility: Advisor/Consultant (); Venatorx: Advisor/Consultant (), Grant/Research Support ()

Lilian M. Abbo, MD, MBA: Ferring: Advisor/Consultant (); Pfizer: Advisor/Consultant (); Regeneron: Grant/Research Support (); Shionogi: Advisor/Consultant ()

Samuel L. Aitken, PharmD, MPH: No financial relationships to disclose

Ahmed Babiker, MBBS, MSc: Beckman Coulter: Advisor/Consultant (Terminated, October 10, 2023); Roche: Advisor/Consultant ()

Jason C. Gallagher, PharmD: Alexion Astra Zeneca Rare Disease: Advisor/Consultant (Ongoing); Entasis: Advisor/Consultant (Ongoing); GSK: Advisor/Consultant (Ongoing); Merck: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Novavax, Inc.: Advisor/Consultant (Ongoing); Qpex: Advisor/Consultant (Ongoing); Shionogi: Advisor/Consultant (Ongoing); Spero: Advisor/Consultant (Ongoing)

Emily L. Heil, PharmD, MS: Wolters Kluwer-LexiComp: Advisor/Consultant (Ongoing)

Megan Klatt, PharmD, BCIDP: No financial relationships to disclose

Wesley D. Kufel, PharmD, BCPS, BCIDP, AAHIVP: Merck and Co: Grant/Research Support (Ongoing)

Conan MacDougall, PharmD, MAS: No financial relationships to disclose

Amy Mathers, MD, D(ABMM): Cepheid, Inc: Advisor/Consultant (Ongoing); DayZeroDiagnositics: Advisor/Consultant (Ongoing); Melinta Therapuetics: Advisor/Consultant (Ongoing); Merck and Co: Advisor/Consultant (Ongoing); Op Gen: Advisor/Consultant (Ongoing); Qpex Biopharma: Advisor/Consultant (Ongoing); Venatorx Pharmaceuticals, Inc.: Advisor/Consultant (Ongoing)

Erin K. McCreary, PharmD: AbbVie Inc: Advisor/Consultant (Ongoing); GSK: Advisor/Consultant (Ongoing), Honoraria (Ongoing); La Jolla Pharmaceuticals: Advisor/Consultant (Terminated, May 1, 2022); LabSimply: Advisor/Consultant (Terminated, October 18, 2022); Merck and Company, Inc.: Advisor/Consultant (Ongoing); Shionogi & Co.,Ltd.: Advisor/Consultant (Ongoing), Honoraria (Ongoing)

Michael J. Satlin, MD: AbbVie: IDMC member (); Biomerieux: Grant/Research Support (); Merck: Grant/Research Support (); SNIPRBiome: Grant/Research Support ()

Pranita Tamma, MD, MHS: No financial relationships to disclose